ADME studies and preliminary safety pharmacology of LDT5, a lead compound for the treatment of benign prostatic hyperplasia
This study aimed to estimate the absorption, distribution, metabolism and excretion (ADME) properties and safety of LDT5, a lead compound for oral treatment of benign prostatic hyperplasia that has previously been characterized as a multi-target antagonist of α1A-, α1D-adrenoceptors and 5-HT1A recep...
| Main Authors: | Noël, F., Nascimento-Viana, J.B., Romeiro, L.A.S., Silva, R.O., Lemes, L.F.N., Oliveira, A.S., Giorno, T.B.S., Fernandes, P.D., Silva, C.L.M. |
|---|---|
| Format: | Artigo |
| Language: | English |
| Published: |
Associação Brasileira de Divulgação Científica
2017
|
| Subjects: | |
| Online Access: |
http://repositorio.unb.br/handle/10482/30084 http://dx.doi.org/10.1590/1414-431x20165542 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|